Tarsus Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Tarsus Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.97M, a 7.86% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.97M -$168K -7.86% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.13M +$1.59M +295% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.88M +$1.31M +227% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.01M +$1.32M +189% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.14M +$1.32M +163% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $540K -$386K -41.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $575K -$499K -46.5% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $696K -$494K -41.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $813K +$273K +50.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $926K +$342K +58.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $1.07M +$386K +56.1% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $1.19M +$431K +56.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $540K Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $584K Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $688K +$562K +446% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $759K Sep 30, 2020 10-Q 2020-11-25
Q4 2019 $126K Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.